advanced search

<< Back To Home

Articles on Measles and Polio by Roland Sutter

Wednesday, 23rd of December 2015

All disease eradication initiatives rest on a foundation of science. Among the most prolific scientific writers on disease eradication is Roland Sutter, of W.H.O. Roland has, since 2000, co-authored 50 open source publications on measles and polio. Here they are.

Those readers who do not wish to read all 47 polio articles can have a look at my personal choice of five polio articles with a direct bearing on endgame and post-eradication issues. Long term excretion of virus in immunodeficient patients, the topic of item 4, is an important topic in countries where clinical services assure the survival of such patients for years, and even decades.

Future historians of polio might wish to take a close look at item 32, “Estimating the extent of vaccine-derived poliovirus infection,” which, the anodyne title notwithstanding, may have marked a turning point in GPEI.

Students of LQAS methodology may find items 13-14 to be of special interest.

Good reading.

BD

Measles

Measles eradication: is it in our future? http://www.sciencedirect.com/science/article/pii/S2210600615000660

Immunogenicity of measles and rubella vaccines in Oman: a prospective clinical trial. http://jid.oxfordjournals.org/content/187/Supplement_1/S177.full.pdf+html

Factors determining prevalence of maternal antibody to measles virus throughout infancy: a review. http://cid.oxfordjournals.org/content/31/1/110.long

Polio   

Articles 1-5 relate to endgame and post-eradication issues

1. The new polio eradication end game: rationale and supporting evidence. http://jid.oxfordjournals.org/content/210/suppl_1/S434.abstract
2. Progress in the development of poliovirus antiviral agents and their essential role in reducing risks that threaten eradication. http://jid.oxfordjournals.org/content/210/suppl_1/S447.long
3. The role of routine polio immunization in the post-certification era. http://www.who.int/bulletin/volumes/82/1/31-39arabic.pdf
4. Poliovirus excretion among persons with primary immune deficiency disorders: summary of a seven-country study series. http://jid.oxfordjournals.org/content/210/suppl_1/S368.long
5. The risks, costs, and benefits of possible future global policies for managing polioviruses. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2424088/

 

 

 

1. Achieving high seroprevalence against polioviruses in Sri Lanka-Results from a serological survey, 2014. http://www.sciencedirect.com/science/article/pii/S2210600615000660

 

1. Update on Vaccine-Derived Polioviruses - Worldwide, January 2014-March 2015. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6423a4.htm

 

1. Immunogenicity of poliovirus vaccines in chronically malnourished infants: a randomized controlled trial in Pakistan. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447616/

 

1. Affordable inactivated poliovirus vaccine: strategies and progress. http://www.ncbi.nlm.nih.gov/pubmed/25316868

 

10.  Effect of buffer on the immune response to trivalent oral poliovirus vaccine in Bangladesh: a community based randomized controlled trial. http://jid.oxfordjournals.org/content/210/suppl_1/S390.long

 

11.  Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden. http://jid.oxfordjournals.org/content/210/suppl_1/S380.long

 

12.  Switch from oral to inactivated poliovirus vaccine in Yogyakarta Province, Indonesia: summary of coverage, immunity, and environmental surveillance. http://jid.oxfordjournals.org/content/210/suppl_1/S347.long

 

13.  Cluster lot quality assurance sampling: effect of increasing the number of clusters on classification precision and operational feasibility. http://jid.oxfordjournals.org/content/210/suppl_1/S341.long

 

14.  Lot quality assurance sampling to monitor supplemental immunization activity quality: an essential tool for improving performance in polio endemic countries. http://jid.oxfordjournals.org/content/210/suppl_1/S333.long

 

15.  Vaccine-derived polioviruses. http://jid.oxfordjournals.org/content/210/suppl_1/S283.long

 

 

 

16.  Outbreaks of paralytic poliomyelitis during 1996-2012: the changing epidemiology of a disease in the final stages of eradication. http://jid.oxfordjournals.org/content/210/suppl_1/S275.full.pdf+html

 

17.  Prevalence of asymptomatic poliovirus infection in older children and adults in northern India: analysis of contact and enhanced community surveillance, 2009. http://jid.oxfordjournals.org/content/210/suppl_1/S252.long

 

18.  Cross-sectional serologic assessment of immunity to poliovirus infection in high-risk areas of northern India. http://jid.oxfordjournals.org/content/210/suppl_1/S243.long

 

19.  A world without polio. http://jid.oxfordjournals.org/content/210/suppl_1/S1.full

 

20.  Polio eradication. Efficacy of inactivated poliovirus vaccine in India. http://www.ncbi.nlm.nih.gov/pubmed/25146288

 

21.  Intestinal immunity is a determinant of clearance of poliovirus after oral vaccination. http://jid.oxfordjournals.org/content/209/10/1628.long

22.  Detection of diphtheritic polyneuropathy by acute flaccid paralysis surveillance, India. http://wwwnc.cdc.gov/eid/article/19/9/13-0117_article

 

23.  Priming after a fractional dose of inactivated poliovirus vaccine. http://www.nejm.org/doi/full/10.1056/NEJMoa1202541

 

 

24.  Waning intestinal immunity after vaccination with oral poliovirus vaccines in India. http://jid.oxfordjournals.org/content/205/10/1554.full.pdf+html

 

 

25.  Randomized trial of type 1 and type 3 oral monovalent poliovirus vaccines in newborns in Africa. http://jid.oxfordjournals.org/content/205/2/228.long

 

 

26.  Guillain-Barré Syndrome in India: population-based validation of the Brighton criteria. http://www.sciencedirect.com/science/article/pii/S0264410X11015787

 

27.  Fractional doses of inactivated poliovirus vaccine in Oman. http://www.nejm.org/doi/full/10.1056/NEJMoa0909383

 

28.  Asymptomatic wild-type poliovirus infection in India among children with previous oral poliovirus vaccination. http://jid.oxfordjournals.org/content/201/10/1535.full

 

 

29.  Randomized controlled clinical trial of fractional doses of inactivated poliovirus vaccine administered intradermally by needle-free device in Cuba. http://jid.oxfordjournals.org/content/201/9/1344.full

 

 

30.  Mucosal immunity after vaccination with monovalent and trivalent oral poliovirus vaccine in India.

Jid.oxfordjournals.org/content/200/5/794.full

 

 

 

31.  Shedding of vaccine viruses with increased antigenic and genetic divergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine. http://jvi.asm.org/content/83/17/8693.full

 

 

 

32.  Estimating the extent of vaccine-derived poliovirus infection. http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0003433

 

33.  Monovalent type 1 oral poliovirus vaccine in newborns. http://www.nejm.org/doi/full/10.1056/NEJMoa0800390

 

34.  New strategies for the elimination of polio from India. http://www.ncbi.nlm.nih.gov/pubmed/17110580

 

35.  A dynamic model of poliomyelitis outbreaks: learning from the past to help inform the future. http://aje.oxfordjournals.org/content/162/4/358.long

 

36.  Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). http://www.cdc.gov/mmwr/preview/mmwrhtml/rr4905a1.htm

 

37.  Polio control after certification: major issues outstanding. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2585872/

 

38.  Persistence of vaccine-derived polioviruses among immunodeficient persons with vaccine-associated paralytic poliomyelitis. http://jid.oxfordjournals.org/content/188/12/1845.full

 

39.  Outbreak of poliomyelitis due to type 3 poliovirus, northern India, 1999-2000: injections a major contributing factor. http://ije.oxfordjournals.org/content/32/2/272.long

 

40.  Compatible poliomyelitis cases in India during 2000. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2572314/

 

41.  Further clarity on vaccine-associated paralytic polio in India. http://www.scielosp.org/scielo.php?pid=S0042-96862002001200018&script=sci_arttext

 

42.  Vaccine-associated paralytic poliomyelitis in India during 1999: decreased risk despite massive use of oral polio vaccine. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2567745/

 

43.  Persistence of vaccine-derived poliovirus following a mass vaccination campaign in Cuba: implications for stopping polio vaccination after global eradication. http://ije.oxfordjournals.org/content/30/5/1029.long

 

44.  Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication. http://paperity.org/p/42773475/sabin-monovalent-oral-polio-vaccines-review-of-past-experiences-and-their-potential-use

 

45.  Differential diagnosis of acute flaccid paralysis and its role in poliomyelitis surveillance. http://epirev.oxfordjournals.org/content/22/2/298.long

 

 

46.  Trial of a supplemental dose of four poliovirus vaccines. http://www.nejm.org/doi/full/10.1056/NEJM200009143431103

 

47.  Widespread paralytic poliomyelitis in Pakistan: A case-control study to determine risk factors and implications for poliomyelitis eradication. http://jid.oxfordjournals.org/content/182/1/6.long